Cargando…
A Simple Dosing Scheme for Intravenous Busulfan Based on Retrospective Population Pharmacokinetic Analysis in Korean Patients
Busulfan is an antineoplastic agent with a narrow therapeutic window. A post-hoc population pharmacokinetic analysis of a prospective randomized trial for comparison of four-times daily versus once-daily intravenous busulfan was carried out to search for predictive factors of intravenous busulfan (i...
Autores principales: | Choe, Sangmin, Kim, Gayeong, Lim, Hyeong-Seok, Cho, Sang-Heon, Ghim, Jong-Lyul, Jung, Jin Ah, Kim, Un-Jib, Noh, Gyujeong, Bae, Kyun-Seop, Lee, Dongho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419763/ https://www.ncbi.nlm.nih.gov/pubmed/22915993 http://dx.doi.org/10.4196/kjpp.2012.16.4.273 |
Ejemplares similares
-
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
por: Cho, Sang-Heon, et al.
Publicado: (2016) -
Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers
por: Kim, Yo Han, et al.
Publicado: (2015) -
Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance
por: Lawson, Rachael, et al.
Publicado: (2022) -
Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019) -
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
por: Pidala, Joseph, et al.
Publicado: (2010)